Fangzhou Inc.
Status: Publicly traded
Direct answer
Fangzhou Inc. is publicly traded on HKSE under the ticker 6086.HK.
Headquartered in Guangzhou, China, Fangzhou Inc. delivers comprehensive online chronic disease management services throughout the nation. The company leverages its dedicated digital platform to assist individuals grappling with long-term health issues like hypertension, cardiovascular, and respiratory conditions. Its mobile application facilitates a suite of "H2H" services, comprising virtual medical consultations,...
Can you invest in Fangzhou Inc.?
Yes. Fangzhou Inc. trades publicly on HKSE as 6086.HK.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Fangzhou Inc.
Detailed equity research is provided by MarketSnap.